Aprea Therapeutics, Inc. ($APRE)
Hamill John P. โ SrVP/CFO/Prin Fin & Acct Ofcr
Shares
10,095
Price
$0.00
Total Value
$0.00
Nearby Earnings
Mar 16, 2026
EPS:-0.32 (est: -0.39)-17.9%
Revenue:$3.34K
Mar 24, 2026
EPS:Est: -0.39
Transaction Details
| Insider | Hamill John P. |
|---|---|
| Title | SrVP/CFO/Prin Fin & Acct Ofcr |
| Transaction Date | Mar 12, 2026 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 16, 2026 |
| Shares Purchased | 10,095 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 43,528 |
| Derivative | No |
| Accession Number | 0001104659-26-028653 |
| Document | View SEC Filing |